Global health experts are urging a rename of Polycystic Ovary Syndrome (PCOS) to Polyendocrine Metabolic Ovarian Syndrome (PMOS). The proposal is intended to better capture the condition’s wider hormonal and metabolic effects, rather than implying that ovarian cysts are the central issue. If adopted, it could reshape awareness, research framing, and patient understanding.
Swipe through stories, personalise your feed, and save articles for later — all on the app.
